Antisense Therapeutics ROA 2024

Antisense Therapeutics Aktienanalyse

What does Antisense Therapeutics do?

Antisense Therapeutics Ltd is an Australian biopharmaceutical company that focuses on developing novel therapies for rare and severe diseases. The company was founded in 1987 and is headquartered in Melbourne. Antisense Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Antisense Therapeutics's Return on Assets (ROA)

Antisense Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Antisense Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Antisense Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Antisense Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Antisense Therapeutics Stock

What is the Return on Assets (ROA) of Antisense Therapeutics this year?

The Return on Assets (ROA) of Antisense Therapeutics is -0.89 undefined this year.

What was the ROA of Antisense Therapeutics compared to the previous year?

The ROA of Antisense Therapeutics has increased by 242.07% compared to the previous year.

What consequences do high ROA have for investors of Antisense Therapeutics?

A high ROA is advantageous for investors of Antisense Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Antisense Therapeutics?

A low ROA can be unfavorable for investors of Antisense Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Antisense Therapeutics affect the company?

An increase in ROA of Antisense Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Antisense Therapeutics impact the company?

A reduction in the ROA of Antisense Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Antisense Therapeutics?

Some factors that can influence the ROA of Antisense Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Antisense Therapeutics important for investors?

The ROA of Antisense Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Antisense Therapeutics take to improve ROA?

To improve ROA, Antisense Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Antisense Therapeutics pay?

Over the past 12 months, Antisense Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Antisense Therapeutics is expected to pay a dividend of 0 AUD.

What is the dividend yield of Antisense Therapeutics?

The current dividend yield of Antisense Therapeutics is .

When does Antisense Therapeutics pay dividends?

Antisense Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Antisense Therapeutics?

Antisense Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Antisense Therapeutics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Antisense Therapeutics located?

Antisense Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Antisense Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Antisense Therapeutics from 6/17/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 6/17/2024.

When did Antisense Therapeutics pay the last dividend?

The last dividend was paid out on 6/17/2024.

What was the dividend of Antisense Therapeutics in the year 2023?

In the year 2023, Antisense Therapeutics distributed 0 AUD as dividends.

In which currency does Antisense Therapeutics pay out the dividend?

The dividends of Antisense Therapeutics are distributed in AUD.